UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 273

Sortiert nach

Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy

PloS one, 2014-06, Vol.9 (2), p.e99026-e99026

2014

Link zum Volltext

Verfügbarkeit prüfen

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression

PloS one, 2019-02, Vol.14 (2), p.e0212254-e0212254

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical Signs of Impending Death in Cancer Patients

The oncologist (Dayton, Ohio), 2014-06, Vol.19 (6), p.681-687

2014

Link zum Volltext

Verfügbarkeit prüfen

Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy

Journal of autoimmunity, 2021-03, Vol.118, p.102593-102593, Article 102593

2021

Link zum Volltext

Verfügbarkeit prüfen

Defining HIV-1 Envelope N-Glycan Microdomains through Site-Specific Heterogeneity Profiles

Journal of virology, 2019-01, Vol.93 (1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Glycosylation Patterns of HIV-1 gp120 Depend on the Type of Expressing Cells and Affect Antibody Recognition

The Journal of biological chemistry, 2010-07, Vol.285 (27), p.20860-20869

2010

Link zum Volltext

Verfügbarkeit prüfen

Colocalization of IgG and IgA Heavy Chains with Kappa and Lambda Light Chains in Glomerular Deposits of IgA Nephropathy Patients Using High-Resolution Confocal Microscopy and Correlation with Oxford MEST-C Scores

Journal of clinical medicine, 2023-11, Vol.12 (23), p.7361

2023

Link zum Volltext

Verfügbarkeit prüfen

Determination of Severity of Murine IgA Nephropathy by Glomerular Complement Activation by Aberrantly Glycosylated IgA and Immune Complexes

The American journal of pathology, 2012-10, Vol.181 (4), p.1338-1347

2012

Link zum Volltext

Verfügbarkeit prüfen

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression

PloS one, 2019-07, Vol.14 (7), p.e0219947-e0219947

2019

Link zum Volltext

Verfügbarkeit prüfen

Development of a Model of Early-Onset IgA Nephropathy

Journal of the American Society of Nephrology, 2012-08, Vol.23 (8), p.1364-1374

2012

Link zum Volltext

Verfügbarkeit prüfen

Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy

Journal of the American Society of Nephrology, 2016-11, Vol.27 (11), p.3278-3284

2016

Link zum Volltext

Verfügbarkeit prüfen

The Serum Very-Low-Density Lipoprotein Serves as a Restriction Factor against Hepatitis C Virus Infection

Journal of virology, 2015-07, Vol.89 (13), p.6782-6791

2015

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal Temporal and Probabilistic Prediction of Survival in a Cohort of Patients With Advanced Cancer

Journal of pain and symptom management, 2014-11, Vol.48 (5), p.875-882

2014

Link zum Volltext

Verfügbarkeit prüfen

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?

Disease markers, 2016-01, Vol.2016, p.7806438-6

2016

Link zum Volltext

Verfügbarkeit prüfen

IgA Vasculitis with Nephritis in Adults: Histological and Clinical Assessment

Journal of clinical medicine, 2021-10, Vol.10 (21), p.4851

2021

Link zum Volltext

Verfügbarkeit prüfen

IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells

Kidney international, 2005-02, Vol.67 (2), p.504-513

2005

Link zum Volltext

Verfügbarkeit prüfen

Louisiana Physicians Are Increasing HPV Vaccination Rates

The Journal of the Louisiana State Medical Society, 2017-05, Vol.169 (3), p.63

2017

Link zum Volltext

Verfügbarkeit prüfen

Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies

iScience, 2020-11, Vol.23 (11), p.101711-101711, Article 101711

2020

Link zum Volltext

Verfügbarkeit prüfen

Identification and Characterization of CMP-NeuAc:GalNAc-IgA1 α2,6-Sialyltransferase in IgA1-producing Cells

Journal of molecular biology, 2007-05, Vol.369 (1), p.69-78

2007

Link zum Volltext

Verfügbarkeit prüfen

Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1

Journal of the American Society of Nephrology, 2019-10, Vol.30 (10), p.2017-2026

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2017-09, Vol.318 (11), p.1047

2017

Link zum Volltext

Verfügbarkeit prüfen

In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells

Results in immunology, 2012, Vol.2, p.166-172

2012

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction

Journal of the American Society of Nephrology, 2017-04, Vol.28 (4), p.1306-1313

2017

Link zum Volltext

Verfügbarkeit prüfen

The IUU Nature of FADs: Implications for Tuna Management and Markets

Coastal management, 2020-11, Vol.48 (6), p.534-558

2020

Link zum Volltext

Verfügbarkeit prüfen

Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy

American journal of physiology. Renal physiology, 2024-05, Vol.326 (5), p.F862

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 273

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(225)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(272)
Japanisch
(37)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression

Clinical Signs of Impending Death in Cancer Patients

Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy

Defining HIV-1 Envelope N-Glycan Microdomains through Site-Specific Heterogeneity Profiles

Glycosylation Patterns of HIV-1 gp120 Depend on the Type of Expressing Cells and Affect Antibody Recognition

Colocalization of IgG and IgA Heavy Chains with Kappa and Lambda Light Chains in Glomerular Deposits of IgA Nephropathy Patients Using High-Resolution Confocal Microscopy and Correlation with Oxford MEST-C Scores

Determination of Severity of Murine IgA Nephropathy by Glomerular Complement Activation by Aberrantly Glycosylated IgA and Immune Complexes

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression

Development of a Model of Early-Onset IgA Nephropathy

Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy

The Serum Very-Low-Density Lipoprotein Serves as a Restriction Factor against Hepatitis C Virus Infection

Longitudinal Temporal and Probabilistic Prediction of Survival in a Cohort of Patients With Advanced Cancer

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?

IgA Vasculitis with Nephritis in Adults: Histological and Clinical Assessment

IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells

Louisiana Physicians Are Increasing HPV Vaccination Rates

Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies

Identification and Characterization of CMP-NeuAc:GalNAc-IgA1 α2,6-Sialyltransferase in IgA1-producing Cells

Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1

Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial

In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells

A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction

The IUU Nature of FADs: Implications for Tuna Management and Markets

Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy

Suchergebnisse filtern